Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis

Table 2 Meta-analysis of hepatitis B virus/hepatitis C virus infection and tumor size in hepatocellular carcinoma

Ref.	Clinicopathological feature	Total	Events (GPC3-positive)	OR	95%CI	P value for OR	P value for heterogeneity
Shirakawa et al[27]	HBV (+/-)	29/78	26/61	1.47	0.53-4.05	0.46	0.10
Yorita et al[29]		60/134	38/59
Ning et al[26]		53/8	26/6
Shirakawa et al[27]	HCV (+/-)	62/45	50/37	0.69	0.42-1.03	0.14	0.54
Yorita et al[29]		83/111	36/61
Yorita et al[29]	Tumor size (≥ 5/< 5)	78/116	41/56	1.15	0.72-1.86	0.56	0.95
Ning et al[26]		37/24	20/12
Yu et al[30]		15/16	10/11

HBV: Hepatitis B virus; HCV: Hepatitis C virus.